162 related articles for article (PubMed ID: 9520236)
41. Involvement of substance P and excitatory amino acids in aversive behavior elicited by intrathecal capsaicin.
Okano K; Kuraishi Y; Satoh M
Neurosci Res; 1994 Mar; 19(2):125-30. PubMed ID: 7516512
[TBL] [Abstract][Full Text] [Related]
42. Non-N-methyl-D-aspartate (NMDA) receptor antagonist 1,2,3, 4-tetrahydro-6-nitro-2,3-dioxo-benzo(f)quinoxaline-7-sulphonamide (NBQX) decreases functional disorders in cytotoxic brain oedema.
Häntzschel A; Andreas K
Arch Toxicol; 2000 Jan; 73(10-11):581-7. PubMed ID: 10663390
[TBL] [Abstract][Full Text] [Related]
43. The effects of intrathecal administration of excitatory amino acid agonists and antagonists on the initiation of locomotion in the adult cat.
Douglas JR; Noga BR; Dai X; Jordan LM
J Neurosci; 1993 Mar; 13(3):990-1000. PubMed ID: 8095068
[TBL] [Abstract][Full Text] [Related]
44. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone.
Vanderah TW; Laughlin T; Lashbrook JM; Nichols ML; Wilcox GL; Ossipov MH; Malan TP; Porreca F
Pain; 1996 Dec; 68(2-3):275-81. PubMed ID: 9121815
[TBL] [Abstract][Full Text] [Related]
45. Effects of excitatory amino acid receptor agonists and antagonists on the secretion of melatonin, luteinizing hormone and prolactin in the ram.
Kumar V; Lincoln GA; Tortonese DJ
J Neuroendocrinol; 1993 Dec; 5(6):649-54. PubMed ID: 8680437
[TBL] [Abstract][Full Text] [Related]
46. Spinal neurokinin3 receptors mediate thermal but not mechanical hyperalgesia via nitric oxide.
Linden DR; Seybold VS
Pain; 1999 Mar; 80(1-2):309-17. PubMed ID: 10204744
[TBL] [Abstract][Full Text] [Related]
47. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus.
Maldonado-Irizarry CS; Swanson CJ; Kelley AE
J Neurosci; 1995 Oct; 15(10):6779-88. PubMed ID: 7472436
[TBL] [Abstract][Full Text] [Related]
48. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat.
Traub RJ
Pain; 1996 Sep; 67(1):151-161. PubMed ID: 8895243
[TBL] [Abstract][Full Text] [Related]
49. Long-term effects of excitatory amino acid antagonists NBQX and MK-801 on the developing brain.
Tandon P; Liu Z; Stafstrom CE; Sarkisian M; Werner SJ; Mikati M; Yang Y; Holmes GL
Brain Res Dev Brain Res; 1996 Sep; 95(2):256-62. PubMed ID: 8874901
[TBL] [Abstract][Full Text] [Related]
50. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors.
Laughlin TM; Vanderah TW; Lashbrook J; Nichols ML; Ossipov M; Porreca F; Wilcox GL
Pain; 1997 Aug; 72(1-2):253-60. PubMed ID: 9272810
[TBL] [Abstract][Full Text] [Related]
51. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia.
Richardson JD; Aanonsen L; Hargreaves KM
J Neurosci; 1998 Jan; 18(1):451-7. PubMed ID: 9412521
[TBL] [Abstract][Full Text] [Related]
52. NBQX is a selective non-NMDA receptor antagonist in rat hippocampal slice.
Goldstein JM; Litwin LC
Mol Chem Neuropathol; 1993; 18(1-2):145-52. PubMed ID: 8385465
[TBL] [Abstract][Full Text] [Related]
53. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury.
Coderre TJ; Melzack R
J Neurosci; 1992 Sep; 12(9):3665-70. PubMed ID: 1326610
[TBL] [Abstract][Full Text] [Related]
54. Acute nociceptive somatic stimulus sensitizes neurones in the spinal cord to colonic distension in the rat.
Peles S; Miranda A; Shaker R; Sengupta JN
J Physiol; 2004 Oct; 560(Pt 1):291-302. PubMed ID: 15284340
[TBL] [Abstract][Full Text] [Related]
55. Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus.
Bordi F; Quartaroli M
Pain; 2000 Feb; 84(2-3):213-24. PubMed ID: 10666526
[TBL] [Abstract][Full Text] [Related]
56. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants.
Wolf ME
Prog Neurobiol; 1998 Apr; 54(6):679-720. PubMed ID: 9560846
[TBL] [Abstract][Full Text] [Related]
57. Redox manipulation of NMDA receptors in vivo: alteration of acute pain transmission and dynorphin-induced allodynia.
Laughlin TM; Kitto KF; Wilcox GL
Pain; 1999 Mar; 80(1-2):37-43. PubMed ID: 10204716
[TBL] [Abstract][Full Text] [Related]
58. Superoxide dismutase activity and the effects of NBQX and CPP on lipid peroxidation in experimental spinal cord injury.
Görgülü A; Kiriş T; Unal F; Turkoğlu U; Küçük M; Cobanoğlu S
Res Exp Med (Berl); 2000 Apr; 199(5):285-93. PubMed ID: 10815757
[TBL] [Abstract][Full Text] [Related]
59. The utility of excitatory amino acid (EAA) antagonists as analgesic agents. I. Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical, thermal and chemical nociceptive tests.
Coderre TJ; Van Empel I
Pain; 1994 Dec; 59(3):345-352. PubMed ID: 7708408
[TBL] [Abstract][Full Text] [Related]
60. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX.
Wrathall JR; Choiniere D; Teng YD
J Neurosci; 1994 Nov; 14(11 Pt 1):6598-607. PubMed ID: 7965063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
